In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapyMickaël Riou, Y. Glupczynski, Daniël De Vos et al.|International Journal of Antimicrobial Agents|2010Cited by 76
<i>In Vitro</i> Susceptibility of Burkholderia cepacia Complex Isolated from Cystic Fibrosis Patients to Ceftazidime-Avibactam and Ceftolozane-TazobactamAnnelien Van Dalem, Denis Piérard|Antimicrobial Agents and Chemotherapy|2018Cited by 44
Hemolytic uremic syndrome in Belgium: incidence and association with verocytotoxin-producing Eschevichia coli infectionDenis Piérard, Sabine Lauwers, Guy Cornu et al.|Clinical Microbiology and Infection|1999Cited by 33
Verocytotoxin-Producing Escherichia coli O128ab:H2 Bacteremia in a 27-Year-Old Male with Hemolytic-Uremic SyndromeGlenn Buvens, Denis Piérard, Flemming Scheutz et al.|Journal of Clinical Microbiology|2013Cited by 16
Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents against Enterobacterales Analyzed by ICU and Non-ICU Wards, Infection Sources, and Geographic Regions: ATLAS Program 2016–2020Denis Piérard, Francis F. Arhin|Antibiotics|2023Cited by 11